Your browser doesn't support javascript.
loading
Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alzheimer's disease.
Agra Almeida Quadros, Ana Rita; Li, Zhaozhi; Wang, Xue; Ndayambaje, I Sandra; Aryal, Sandeep; Ramesh, Nandini; Nolan, Matthew; Jayakumar, Rojashree; Han, Yi; Stillman, Hannah; Aguilar, Corey; Wheeler, Hayden J; Connors, Theresa; Lopez-Erauskin, Jone; Baughn, Michael W; Melamed, Ze'ev; Beccari, Melinda S; Olmedo Martínez, Laura; Canori, Michael; Lee, Chao-Zong; Moran, Laura; Draper, Isabelle; Kopin, Alan S; Oakley, Derek H; Dickson, Dennis W; Cleveland, Don W; Hyman, Bradley T; Das, Sudeshna; Ertekin-Taner, Nilüfer; Lagier-Tourenne, Clotilde.
Affiliation
  • Agra Almeida Quadros AR; Department of Neurology, The Sean M. Healey and AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Li Z; Department of Neurology, MassGeneral Institute for Neurodegenerative Diseases (MIND), Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Wang X; Broad Institute of Harvard University and MIT, Cambridge, MA, USA.
  • Ndayambaje IS; Department of Neurology, MassGeneral Institute for Neurodegenerative Diseases (MIND), Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Aryal S; Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL, USA.
  • Ramesh N; Department of Neurology, The Sean M. Healey and AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Nolan M; Department of Neurology, MassGeneral Institute for Neurodegenerative Diseases (MIND), Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Jayakumar R; Department of Neurology, The Sean M. Healey and AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Han Y; Department of Neurology, MassGeneral Institute for Neurodegenerative Diseases (MIND), Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Stillman H; Broad Institute of Harvard University and MIT, Cambridge, MA, USA.
  • Aguilar C; Department of Neurology, The Sean M. Healey and AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Wheeler HJ; Department of Neurology, MassGeneral Institute for Neurodegenerative Diseases (MIND), Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Connors T; Broad Institute of Harvard University and MIT, Cambridge, MA, USA.
  • Lopez-Erauskin J; Department of Neurology, The Sean M. Healey and AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Baughn MW; Department of Neurology, MassGeneral Institute for Neurodegenerative Diseases (MIND), Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Melamed Z; Broad Institute of Harvard University and MIT, Cambridge, MA, USA.
  • Beccari MS; Department of Neurology, MassGeneral Institute for Neurodegenerative Diseases (MIND), Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Olmedo Martínez L; Department of Neurology, The Sean M. Healey and AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Canori M; Department of Neurology, MassGeneral Institute for Neurodegenerative Diseases (MIND), Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Lee CZ; Department of Neurology, The Sean M. Healey and AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Moran L; Department of Neurology, MassGeneral Institute for Neurodegenerative Diseases (MIND), Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Draper I; Department of Neurology, The Sean M. Healey and AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Kopin AS; Department of Neurology, MassGeneral Institute for Neurodegenerative Diseases (MIND), Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Oakley DH; Department of Neurology, The Sean M. Healey and AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Dickson DW; Department of Neurology, MassGeneral Institute for Neurodegenerative Diseases (MIND), Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Cleveland DW; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Hyman BT; Department of Cellular and Molecular Medicine, University of California at San Diego, La Jolla, CA, USA.
  • Das S; Department of Cellular and Molecular Medicine, University of California at San Diego, La Jolla, CA, USA.
  • Ertekin-Taner N; Department of Cellular and Molecular Medicine, University of California at San Diego, La Jolla, CA, USA.
  • Lagier-Tourenne C; Department of Cellular and Molecular Medicine, University of California at San Diego, La Jolla, CA, USA.
Acta Neuropathol ; 147(1): 9, 2024 01 04.
Article in En | MEDLINE | ID: mdl-38175301
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pick Disease of the Brain / Frontotemporal Dementia / Alzheimer Disease / Amyotrophic Lateral Sclerosis Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Acta Neuropathol Year: 2024 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pick Disease of the Brain / Frontotemporal Dementia / Alzheimer Disease / Amyotrophic Lateral Sclerosis Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Acta Neuropathol Year: 2024 Document type: Article Affiliation country: Country of publication: